These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1455393)

  • 1. Prolonged bleeding time in patients with lupus anticoagulant.
    Orlando E; Cortelazzo S; Marchetti M; Sanfratello R; Barbui T
    Thromb Haemost; 1992 Nov; 68(5):495-9. PubMed ID: 1455393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of plasma from patients with primary antiphospholipid syndrome on platelet function in a collagen rich perfusion system.
    Reverter JC; Tàssies D; Escolar G; Font J; López Soto A; Ingelmo M; Ordinas A
    Thromb Haemost; 1995 Jan; 73(1):132-7. PubMed ID: 7740485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged bleeding time and lupus anticoagulant: a second paradox in the antiphospholipid syndrome.
    Urbanus RT; de Laat HB; de Groot PG; Derksen RH
    Arthritis Rheum; 2004 Nov; 50(11):3605-9. PubMed ID: 15529374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study of antiphospholipid antibodies in 50 cases of bad obstetric history.
    Kaneria MV; Vishwanathan C
    J Assoc Physicians India; 1999 Jul; 47(7):669-72. PubMed ID: 10778583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiolipin antibodies and lupus anticoagulant in young patients with a cerebrovascular accident in the past.
    de Jong AW; Hart W; Terburg M; Molenaar JL; Herbrink P; Hop WC
    Neth J Med; 1993 Apr; 42(3-4):93-8. PubMed ID: 8316330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies: an epiphenomenon in Tourette syndrome.
    Singer HS; Krumholz A; Giuliano J; Kiessling LS
    Mov Disord; 1997 Sep; 12(5):738-42. PubMed ID: 9380057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
    Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of antiphospholipid antibodies in patients treated with antiepileptic drugs.
    Pardo A; González-Porque P; Gobernado JM; Jiménez-Escrig A; Lousa M
    Neurologia; 2001 Jan; 16(1):7-10. PubMed ID: 11234666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation.
    Campbell AL; Pierangeli SS; Wellhausen S; Harris EN
    Thromb Haemost; 1995 Mar; 73(3):529-34. PubMed ID: 7667838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies: lupus anticoagulants, anticardiolipin and antiphospholipid isotypes in patients with sickle cell disease.
    Nsiri B; Ghazouani E; Gritli N; Mazigh C; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
    Hematol Cell Ther; 1998 Jun; 40(3):107-12. PubMed ID: 9698218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lupus anticoagulants in patients with systemic lupus erythematosus].
    Matsuura Y; Nawata Y; Miike S; Hiraguri M; Kita Y; Kurasawa K; Takabayashi K; Oh H; Iwamoto I; Saito Y
    Ryumachi; 1996 Feb; 36(1):16-24. PubMed ID: 8711533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.